During its first-quarter earnings report this spring, Philips ... machines. This is the latest action over the machines, which were recalled in 2021. The 2021 recall was mostly around DreamStation ...

ResMed Inc . (NYSE:RMD; ASX:RMD), a leading player in the sleep and respiratory care market, has demonstrated strong operational performance in recent quarters. However, the company faces potential ...

Medical device company Philips reached a settlement ... surrounded the brand's popular DreamStation CPAP, or continuous ...

One of the most common treatments for obstructive sleep apnea is continuous positive airway pressure (CPAP ... Philips System One, which he personally uses, but there are also bundles for ResMed ...

The global OSA homecare device market, is a two-player duopoly with over 80% estimated market share split between ResMed and Philips ... airway pressure, or CPAP, with another 34 million remaining ...

The company's consistent performance has been marked by significant market share gains, partly attributed to issues faced by competitor Philips ... CPAP device market, potentially reducing ResMed ...

Its core business includes the development of devices for sleep apnea -- such as CPAP and APAP machines -- and digital health solutions. Key success factors for ResMed include maintaining ...